Verition Fund Management »

Mersana Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 564k 4.48
2023-09-30 $208k 164k 1.27
2022-09-30 $110k 16k 6.74

More positions owned by Verition Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
salesforce Call Option (CRM)
Apple Call Option (AAPL)
Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Ishares Msci Brazil Etf Put Option (EWZ)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Goldman Sachs (GS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Sea Note 2.375%12/0 (Principal)

View all positions for Verition Fund Management

Top funds holding Mersana Therapeutics

EcoR1 Capital
VR Adviser
Bain Capital Life Sciences Investors
BlackRock
Vanguard Group
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Rock Springs Capital Management
Morgan Stanley
Woodline Partners
Cormorant Asset Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Millennium Management

View all funds holding Mersana Therapeutics